LDS/Medical Tests/Spinocerebellar Ataxia, Ataxin 8 (ATXN8OS) Gene Mutation Analysis

Spinocerebellar Ataxia, Ataxin 8 (ATXN8OS) Gene Mutation Analysis

Spinocerebellar ataxias (SCAs) are a clinically and genetically heterogeneous group of autosomal dominant neurodegenerative disorders characterized by progressive cerebellar dysfunction. SCA8 is a slow progressive form typically presenting between the third and fifth decades of life, manifesting as limb and gait ataxia, dysarthria, oculomotor abnormalities, extrapyramidal signs, sensory neuropathy, and occasionally cognitive impairment.

The ATXN8OS gene, located on chromosome 13q21, is transcribed in the opposite direction to the ATXN8 gene. Mutations in this region cause spinocerebellar ataxia type 8 (SCA8), resulting from expansion of a CTA/CTG trinucleotide repeat in the untranslated region (UTR) of the ATXN8/ATXN8OS gene complex. The expansion leads to RNA-mediated neurotoxicity, disrupting normal neuronal function.

Although large repeat expansions are associated with disease, reduced penetrance and variable expressivity are common, as repeat lengths in the pathogenic range have also been observed in asymptomatic individuals. Distinguishing SCA8 from other subtypes can be challenging, but key distinguishing features include slower disease progression, absence of retinal degeneration, preserved sensory nerve function, and infrequent seizure occurrence.

  • Confirms diagnosis of spinocerebellar ataxia type 8 (SCA8)
  • Supports risk assessment and predictive testing in at-risk family members
  • Aids in genetic counseling and clinical management of hereditary ataxia
  • Aid in differential diagnosis of neurodegenerative diseases

Results are based on the size of the (CTA.TAG)n(CTG.CAG)n repeat expansion:

Repeat Range Interpretation / Clinical Significance

  • 15–50 repeats  Normal range

Variable repeat sizes  Reduced penetrance; may or may not be associated with ataxia

  • 54–250 repeats  Observed in individuals with ataxia; however, sizes between 70–130 repeats have also been found in asymptomatic individuals

15 to 50 (CTA.TAG)n(CTG.CAG)n repeats

Next generation sequencing, Bi-directional sanger sequencing, repeat expansion detection by PCR, gel electrophoresis, deletion/duplication analysis.

Whole blood (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: unacceptable
Ceruloplasmin, Fragile X FMR1 gene mutation analysis, thyroid stimulating hormone, microsatellite instability testing (MSI).
7 to 14 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login